Back to YC Companies
Indee Labs
Winter 2017
Active
Enabling T cell immunotherapy discovery, development and manufacturing
5 people View on YC
Indee Labs at a glance
- Y Combinator batch
- Winter 2017
- Status
- Active
- Industry
- Healthcare
- Team size
- 5 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Indee Labs
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.
Tags:
Gene Therapy
Microfluidics
Cell Therapy